603676.SH
Xizang Weixinkang Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.14
−2.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.08x
- PEG TTM
- 0.56x
- Price / book
- 2.71x
- Price / sales
- 3.27x
- Price / cash flow
- 17.01x
Enterprise value
- Enterprise value
- CNY 3.5B
- EV / sales
- 3.05x
- EV / EBITDA
- 10.49x
- EV / EBIT
- 12.78x
- Market cap
- CNY 4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026